scholarly journals Early Neospora caninum infection dynamics in cattle after inoculation at mid-gestation with high (Nc-Spain7)- or low (Nc-Spain1H)-virulence isolates

2019 ◽  
Vol 50 (1) ◽  
Author(s):  
Laura Jiménez-Pelayo ◽  
Marta García-Sánchez ◽  
Patricia Vázquez ◽  
Javier Regidor-Cerrillo ◽  
Pilar Horcajo ◽  
...  

Abstract Early Neospora caninum infection dynamics were investigated in pregnant heifers intravenously inoculated with PBS (G-Control) or 107 tachyzoites of high (G-NcSpain7)- or low (G-NcSpain1H)-virulence isolates at 110 days of gestation. Serial culling at 10 and 20 days post-infection (dpi) was performed. Fever was detected at 1 dpi in both infected groups (P < 0.0001), and a second peak was detected at 3 dpi only in G-NcSpain7 (P < 0.0001). At 10 dpi, Nc-Spain7 was detected in placental samples from one animal related to focal necrosis, and Nc-Spain7 transmission was observed, although no foetal lesions were associated with this finding. The presence of Nc-Spain1H in the placenta or foetuses, as well as lesions, were not detected at 10 dpi. At 20 dpi, G-NcSpain7 animals showed almost 100% positive placental tissues and severe focal necrosis as well as 100% transmission. Remarkably, foetal mortality was detected in two G-NcSpain7 heifers. Only one animal from G-NcSpain1H presented positive placental samples. No foetal mortality was detected, and lesions and parasite transmission to the foetus were not observed in this group. Finally, 100% of G-NcSpain7 heifers at 20 dpi presented specific antibodies, while only 60% of G-NcSpain1H animals presented specific antibodies at 20 dpi. In addition, earlier seroconversion in G-Nc-Spain7 was observed. In conclusion, tachyzoites from Nc-Spain7 reached the placenta earlier and multiplied, leading to lesion development, transmission to the foetus and foetal mortality, whereas Nc-Spain1H showed delayed infection of the placenta and no lesional development or transmission during early infection.

2012 ◽  
Vol 111 (2) ◽  
pp. 717-721 ◽  
Author(s):  
Marcelo Piagentini ◽  
Carla Fredrichsen Moya-Araujo ◽  
Nereu Carlos Prestes ◽  
Izidoro Francisco Sartor

2014 ◽  
Vol 45 (1) ◽  
pp. 10 ◽  
Author(s):  
Javier Regidor-Cerrillo ◽  
David Arranz-Solís ◽  
Julio Benavides ◽  
Mercedes Gómez-Bautista ◽  
José Antonio Castro-Hermida ◽  
...  

1995 ◽  
Vol 36 (3) ◽  
pp. 387-391
Author(s):  
A. Flagstad ◽  
Η. Ε. Jensen ◽  
Ι. Bjerkàs ◽  
Κ. Rasmussen

2017 ◽  
Vol 242 ◽  
pp. 22-23 ◽  
Author(s):  
Qing-Feng Meng ◽  
Gui-Zhe Yao ◽  
Si-Yuan Qin ◽  
Jian Wu ◽  
Xi-Chen Zhang ◽  
...  

Author(s):  
José Luis Salguero-Romero ◽  
Dora Romero-Salas ◽  
Anabel Cruz-Romero ◽  
Miguel A. Alonso-Díaz ◽  
Mariel Aguilar-Domínguez ◽  
...  

2006 ◽  
Vol 77 (3-4) ◽  
pp. 254-283 ◽  
Author(s):  
Barbara Häsler ◽  
Katharina D.C. Stärk ◽  
Heinz Sager ◽  
Bruno Gottstein ◽  
Martin Reist

2018 ◽  
Vol 18 (15) ◽  
pp. 1304-1323 ◽  
Author(s):  
Roberto Sánchez-Sánchez ◽  
Patricia Vázquez ◽  
Ignacio Ferre ◽  
Luis Miguel Ortega-Mora

Toxoplasmosis and neosporosis are closely related protozoan diseases that lead to important economic impacts in farm ruminants. Toxoplasma gondii infection mainly causes reproductive failure in small ruminants and is a widespread zoonosis, whereas Neospora caninum infection is one of the most important causes of abortion in cattle worldwide. Vaccination has been considered the most economic measure for controlling these diseases. However, despite vaccine development efforts, only a liveattenuated T. gondii vaccine has been licensed for veterinary use, and no promising vaccines against neosporosis have been developed; therefore, vaccine development remains a key goal. Additionally, drug therapy could be a valuable strategy for disease control in farm ruminants, as several drugs that limit T. gondii and N. caninum proliferation and dissemination have been evaluated. This approach may also be relevant to performing an initial drug screening for potential human therapy for zoonotic parasites. Treatments can be applied against infections in adult ruminants to minimize the outcomes of a primo-infection or the reactivation of a chronic infection during gestation or in newborn ruminants to avoid infection chronification. In this review, the current status of drug development against toxoplasmosis and neosporosis in farm ruminants is presented, and in an effort to promote additional treatment options, prospective drugs that have shown efficacy in vitro and in laboratory animal models of toxoplasmosis and neosporosis are examined.


Sign in / Sign up

Export Citation Format

Share Document